| Serial Number | 76042789 |
| Word Mark | ENTRESE |
| Filing Date | Monday, May 8, 2000 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Friday, November 9, 2001 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, February 13, 2001 |
| Goods and Services | pharmaceutical and medicinal preparations for treatment of diabetes; pharmaceutical and medicinal preparations for treatment of diseases and disorders related to diabetes; pharmaceutical and medicinal preparations for treatment of sexual dysfunction; pharmaceutical and medicinal preparations for treatment of macular degeneration |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 19, 2000 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Eli Lilly and Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285 |
| Party Name | Eli Lilly and Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285 |
| Event Date | Event Description |
| Thursday, April 18, 2002 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, May 8, 2001 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 13, 2001 | PUBLISHED FOR OPPOSITION |
| Friday, January 12, 2001 | NOTICE OF PUBLICATION |
| Wednesday, September 27, 2000 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 27, 2000 | ASSIGNED TO EXAMINER |